Antigen receptors and uses thereof

Anti-CD19 humanized antibody and immune effector cell targeting cd 19

Peptide-MHC compacts

Modified Latency Associated Protein Construct

Methods and compositions for synthesizing improved silk fibers

CELLS EXPRESSING A BCMA-TARGETING CHIMERIC ANTIGEN RECEPTOR, AND COMBINATION THERAPY WITH A GAMMA SECRETASE INHIBITOR

Antitumor peptide having PD-1 signal sequence and utilization thereof

Chimeric chlorotoxin receptors

Non-human animals having a humanized programmed cell death 1 gene

Microorganisms expressing modified glucoamylase enzymes

Reporter protein fused antibodies

T cell receptors that bind to NY-ESO-1 and methods of use thereof

CHIMERIC ANTIGEN RECEPTORS (CARs) HAVING MUTATIONS IN THE FC SPACER REGION AND METHODS FOR THEIR USE

SECRETABLE VARIANT IMMUNOMODULATORY PROTEINS AND ENGINEERED CELL THERAPY

GENOME-EDITED INVARIANT NATURAL KILLER T (INKT) CELLS FOR THE TREATMENT OF HEMATOLOGIC MALIGNANCIES

Ligands Modified by Circular Permutation as Agonists and Antagonists

MULTI-FUNCTION AND MULTI-TARGETING CAR SYSTEM AND METHODS FOR USE THEREOF

Gamma delta T cells and a method of augmenting the tumoricidal activity of the same

Co-stimulatory domains for use in genetically-modified cells

Zika virus vaccines

Humanized anti-CD19 antibody and use thereof with chimeric antigen receptor

POLYPEPTIDES HAVING CELLULOLYTIC ENHANCING ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME

Engineered DNase enzymes and use in therapy

Chimeric antigen receptors (CARs), compositions and methods thereof

RNA-guided nucleic acid modifying enzymes and methods of use thereof

Unstructured non-repetitive polypeptides having LCST behavior

CELL

Cell

MODULATION OF NOVEL IMMUNE CHECKPOINT TARGETS

METHODS FOR THE TREATMENT OF B CELL MALIGNANCIES USING ADOPTIVE CELL THERAPY

5T4-targeting agents and methods

Compositions and methods for treating cancer with anti-CD123 immunotherapy

CONTROL SELF-CLEAVING PROTEIN ACTIVITY AND APPLICATION THEREOF

CS1-specific chimeric antigen receptor engineered immune effector cells

Chimeric transmembrane proteins and uses thereof

Construction of chimeric antigen receptor targeting CD20 antigen and activity identification of engineered T cells thereof

Donor repair templates multiplex genome editing

BCMA (CD269) specific chimeric antigen receptors for cancer immunotherapy

CONSTRUCTION AND APPLICATION OF RECOMBINANT GENE FOR CHIMERIC ANTIGEN RECEPTOR FOR TREATING HIV INFECTION

CD28 compositions and methods for chimeric antigen receptor therapy

SpyCatcher and SpyTag: universal immune receptors for T cells

Claudin-6-specific immunoreceptors and t cell epitopes

Nucleic acid constructs comprising gene editing multi-sites and uses thereof

Compositions and methods for producing polypeptides with a modified glycosylation pattern in plant cells

BCMA chimeric antigen receptors and uses thereof

Hybrid proteins and uses thereof

Primary cell gene editing

Primary cell gene editing

ANTIGEN-BINDING PROTEINS TARGETING MELANOMA DIFFERENTIATION ANTIGENS AND USES THEREOF

MUC16 specific chimeric antigen receptors and uses thereof

Compositions and methods of muscle specific kinase chimeric autoantibody receptor cells

Zika virus vaccines

CTLA4/PD1 targeted/immunomodulatory fusion proteins

Anti-GPC3 antibody

Bispecific signaling agents and uses thereof

VC-CAR molecule and use thereof in removing HIV-1 infected cells

CALRETICULIN AND FUSION PROTEINS

Regulating chimeric antigen receptors

Natural killer cell expressing anti-cotinine chimeric antigen receptor

Materials and methods for engineering cells and uses thereof in immuno-oncology

Materials and methods for engineering cells and uses thereof in immuno-oncology

Chimeric antigen receptors and uses thereof

Method of increasing resistance to a fungal pathogen by applying a hydrophobin to a plant

FUSION PROTEIN AND APPLICATIONS THEREOF

BCMA-targeting antibody and use thereof

Antibody targeting IL-13RA2 and use thereof

Anti-GPC3 antibody

Chimeric antigen receptor effector cell switches with humanized targeting moieties and/or optimized chimeric antigen receptor interacting domains and uses thereof

NOVEL MINOR HISTOCOMPATIBILITY ANTIGENS AND USES THEREOF

Fusion polypeptides comprising one or more inclusion body tags, methods and uses

ADOPTIVE TRANSFER OF CAR T CELLS WITH SURFACE-CONJUGATED DRUG-LOADED NANOPARTICLES AND USES THEREOF

Human monoclonal antibodies specific for FLT3 and uses thereof

Clec9A binding agents

Universal chimeric antigen expressing immune cells for targeting of diverse multiple antigens and method of manufacturing the same and use of the same for treatment of cancer, infections and autoimmune disorders

Use of the CD2 signaling domain in second-generation chimeric antigen receptors

Fused in sarcoma (FUS) nuclear translocation inhibitors for preventing fibrosis

TGFBeta signal convertor

DENDRITIC CELL PREPARATIONS, COMPOSITIONS THEREOF AND METHODS OF USING SAME

ASPARTATE BETA-HYDROXYLASE CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF

RP215 chimeric antigen receptor construct and methods of making and using same

Binding proteins and chimeric antigen receptor T cells targeting GASP-1 granules and uses thereof

Peptide-HLA complexes and methods of producing same

TARGETED T CELLS WITH CYTOTOXICITY TOWARD IMMUNOSUPPRESSIVE CELLS

Gene therapy constructs and methods of use

Constructs targeting histone H3 peptide/MHC complexes and uses thereof

Anti-PD-L1 and IL-2 cytokines

CD47-CAR-T cells

CELL DEATH INDUCING CHIMERIC ANTIGEN RECEPTORS

Fusion proteins containing insulin-like growth factor-1 and epidermal growth factor and variants thereof and uses thereof

GENETICALLY ENGINEERED VACCINIA VIRUSES

CD133-binding agents and uses thereof

ANTI-PD-L1 ANTIBODIES

Methods and compositions relating to ex vivo culture and modulation of T cells

CD229 CAR T cells and methods of use thereof

Tunable Chimeric Antigen Receptors

Compositions and Methods for Modulating the Immune System

Chimeric antigen receptors based on alternative signal 1 domains

Signalling system

HV1 modulators and uses

Viral vector constructs for expression of genetic adjuvants activating the STING pathway

Human cytomegalovirus RNA vaccines

Compositions and methods for inhibition of lineage specific antigens

Reducing immune tolerance induced by PD-L1

ADAPTER CHIMERIC ANTIGEN RECEPTOR EXPRESSING CELLS FOR TARGETING OF MULTIPLE ANTIGENS

Antibody agents specific for human CD19 and uses thereof

Compositions and methods of chimeric autoantibody receptor T cells

Compositions and methods of chimeric autoantibody receptor T cells

Compositions and methods of chimeric autoantibody receptor T cells

COMPOSITIONS AND METHODS FOR INHIBITION OF LINEAGE SPECIFIC ANTIGENS

Materials and methods for engineering cells and uses thereof in immuno-oncology

Materials and methods for engineering cells and uses thereof in immuno-oncology

PHI-4 polypeptides and methods for their use

Dual cistronic bacterial expression system

SIGNAL TRANSDUCTION MODIFYING PROTEIN

Compositions and methods of chimeric autoantibody receptor T cells

CRYPTIC POLYPEPTIDES AND USES THEREOF

Synthetic malaria immunogens, combinations thereof, and their use to prevent and treat malaria infections

ENGINEERED LYMPHOCYTES

TARGET RECOGNITION MOTIFS AND USES THEREOF

DESTABILISING DOMAINS FOR CONDITIONALLY STABILISING A PROTEIN

Engineered CD46-specific effector cells and uses thereof in the treatment of cancer

Conjugates of IL13Rα2 binding agents and use thereof in cancer treatment

IL-15-based fusions to IL-7 and IL-21

IL6R block CAR-T transgenic vector for alleviating CRS, preparation method thereof

Inducible chimeric cytokine receptors

NOVEL BINDING PROTEINS COMPRISING A UBIQUITIN MUTEIN AND ANTIBODIES OR ANTIBODY FRAGMENTS

Anti-alpha-synuclein antibodies and methods of use

CELL EXPRESSING CAR AND GPCR

USE OF ANTIBODY-COUPLED T CELL RECEPTOR (ACTR) WITH MULTIPLE ANTI-CANCER ANTIBODIES IN CANCER TREATMENT

COMPOSITIONS AND METHODS FOR T-CELL AND CYTOKINE ACTIVATION

RNA-guided nucleic acid modifying enzymes and methods of use thereof

Integral membrane protein display on poxvirus extracellular enveloped virions

TAG-72-binding chimeric antigen receptors

ADAPTIVE CHIMERIC ANTIGEN RECEPTOR T-CELL DESIGN

BAFF-R targeted chimeric antigen receptor-modified t-cells and uses thereof

Genetically modified probiotics for oral delivery of renin-angiotensin related therapeutic proteins and peptides

NON-HUMAN ANIMAL EXHIBITING DIMINISHED UPPER AND LOWER MOTOR NEURON FUNCTION AND SENSORY PERCEPTION

Expression of chimeric polypeptide with variable lymphocyte receptors on immune cells and uses for treating cancer

Compositions and methods for TCR reprogramming using fusion proteins

Drug regulated transgene expression

Programmable protein circuits in living cells

A UNIVERSAL PLATFORM FOR CAR THERAPY TARGETING A NOVEL ANTIGENIC SIGNATURE OF CANCER

BSL2v2c2-Ig polypeptides

Methods and compositions for treating cancer

Listeria-Based Immunogenic Compositions Comprising Wilms Tumor Protein Antigens And Methods Of Use Thereof

RECOMBINANT NEL-LIKE (MELL) PROTEIN PRODUCTION

Heat-stable metagenomic carbonic anhydrases and their use

Chimeric antigen receptors targeting B-cell maturation antigen

Compositions and methods for treating cancer with DuoCARs

Platform for enhanced targeted delivery

Chimeric antigen receptor for efficient selective proliferation in vitro and uses thereof

Chimeric antigen receptors targeting CD70

Co-stimulatory domains for use in genetically-modified cells

Genomic integration of DNA fragments in fungal host cells

Multimers, tetramers and octamers

HPV-specific binding molecules

Targeted Therapeutic Proteins

Fusion protein, polynucleotide, genetic construct, producer, preparation for regeneration of cartilage

Compositions and methods for treating cancer with anti-mesothelin immunotherapy

Method for screening drug and therapeutic targets used for treating Alzheimer's disease

Genetically-modified cells and method for producing same

MULTISPECIFIC ANTIBODIES FOR IMMUNO-ONCOLOGY

Chimeric antigen receptors targeting CD-19

Compositions and methods for treating HIV/AIDS with immunotherapy

Exosomes for immuno-oncology and anti-inflammatory therapy

Polypeptides modulating SIGLEC dependent immune responses

Engineered bacteria secreting therapeutic proteins and methods of use thereof

GENETICALLY-MODIFIED CELLS COMPRISING A MODIFIED HUMAN T CELL RECEPTOR ALPHA CONSTANT REGION GENE

Methods of making bispecific anti-CD307E and anti-BCMA chimeric antigen receptors and uses of the same

Fusion proteins for inhibiting angiogenesis

Vaccines for human papilloma virus and methods for using the same

Optimized factor VIII genes

INHIBITORS

Methods and compositions for treating and preventing HIV

Human Notch1 based fusion proteins as decoy inhibitors of jagged-notch signaling and DLL-notch signaling

Recombinant influenza virus-like particles (VLPS) produced in transgenic plants

Method of producing a recombinant protein

Compositions and methods for TCR reprogramming using fusion proteins

Chimeric antigen receptors having GITR intracellular domain as co-stimulatory domain

A METHOD FOR HIGH LEVEL AND STABLE GENE TRANSFER IN LYMPHOCYTES

Immunotherapy methods using anti-PD-L1 antibodies in combination with EGFR1 targeted-TGF-beta immunomodulatory fusion proteins

Recombinant obligate anaerobic Gram-positive bacteria

Targeting PD-L1 on tumor cells

Optimized PNE-based chimeric receptor T cell switches and uses thereof

Glycosylated VWF fusion proteins with improved pharmacokinetics

Chimeric antigen receptors specific for B-cell maturation antigen and encoding polynucleotides

CHIMERIC ANTIGEN RECEPTOR T CELL COMPOSITIONS

Affinity-enhanced monomeric streptavidin chimeric antigen receptor (CAR)

Genetically modified rat comprising a humanized locus

Chimeric antigen receptors and uses thereof

COMPOSITIONS AND METHODS OF CHIMERIC ALLOANTIGEN RECEPTOR T CELLS

Filovirus consensus antigens, nucleic acid constructs and vaccines made therefrom, and methods of using same

Fusion protein between short form rod-derived cone viability factor and a hydrophilic peptide

COMPOSITIONS AND METHODS FOR IMMUNOTHERAPY

Compositions and methods of cellular immunotherapy

POLYNUCLEOTIDE ENCODING FUSION OF ANCHORING MOTIF AND DEHALOGENASE, HOST CELL INCLUDING THE POLYNUCLEOTIDE, AND USE THEREOF

Methods for treating or preventing HBV infection or HBV related diseases

Anti-CD7 chimeric antigen receptor and method of use thereof

Modified kappa light chain-binding polypeptides

Polypeptides having xylanase activity and polynucleotides encoding same

GENETICALLY ENGINEERED CELLS AND METHODS OF MAKING THE SAME

Cell based anti-cancer compositions with reduced toxicity and methods of making the same

COMPOUND CHIMERIC ANTIGEN RECEPTOR (cCAR) TARGETING MULTIPLE ANTIGENS, COMPOSITIONS AND METHODS OF USE THEREOF

High affinity B7-H6 antibodies and antibody fragments

IMMUNOMODULATORY IL2R FUSION PROTEINS AND USES THEREOF

RSV F protein mutants

HLA-G AS A NOVEL TARGET FOR CAR T-CELL IMMUNOTHERAPY

Pesticidal fusion protein improvements

Integral membrane protein display on poxvirus extracellular enveloped virions

CHIMERIC ANTIGEN RECEPTORS TARGETING CANCER

MODIFIED CHIMERIC RECEPTORS AND USES THEREOF IN IMMUNE THERAPY

Highly sensitive and specific luciferase based reporter assay for antigen detection

Expression of proteins in gram-negative bacteria wherein the ratio of periplasmic volume to cytoplasmic volume is between 0.5:1 and 10:1

Compositions and methods for treating cancer with anti-CD19 immunotherapy

Modified interleukin-7 protein

Antiviral peptide and use therefor

METHODS OF USING INTERLEUKIN-10 FOR TREATING DISEASES AND DISORDERS

Engineering gut commensal bacteria to express heterologous proteins in their outer membrane vesicles (OMVs) for delivery to the GI-tract

Compositions and methods for treating cancer with anti-CD22 immunotherapy

Subcutaneous Delivery of Adenovirus with Dual Targeting

Use of car and bite technology coupled with an ScFv from an antibody against human thymidine kinase 1 to specifically target tumors

Methods and compositions for car T cell therapy

COMPOSITIONS, METHODS, AND COMPUTER SYSTEMS RELATED TO MAKING AND ADMINISTERING MODIFIED T CELLS

Anti-Sialyl Tn chimeric antigen receptors

CHIMERIC ANTIGEN RECEPTORS AND METHODS OF MAKING

M971 chimeric antigen receptors

gene with lepidopteran activity

Polypeptides Having Immunoactivating Activity And Methods Of Producing The Same

Compositions and methods for treating cancer with DuoCARs

CD8 binding agents

Methods of producing aggregate-free monomeric diphtheria toxin fusion proteins and therapeutic uses

Use of car and bite technology coupled with an SCFV from an antibody against human thymidine kinase 1 to specifically target tumors

Use of car and bite technology coupled with an SCFV from an antibody against human thymidine kinase 1 to specifically target tumors

Modulating gamma-c-cytokine activity

IMMUNE CELLS HAVING INCREASED IMMUNITY OR RESISTANCE TO AN IMMUNOSUPPRESSIVE CYTOKINE AND USE OF THE SAME

Optimized lentiviral transfer vectors and uses thereof

RECOMBINANT ELASTASE PROTEINS AND METHODS OF MANUFACTURING AND USE THEREOF

Engineered antigen presenting cells and uses thereof

ACVR1-FC FUSION PROTEIN, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF

Improved Therapeutic Control of Proteolytically Sensitive, Destabilized Forms of Interleukin-12

Fusion proteins for promoting an immune response, nucleic acids encoding same, and methods of making and use thereof

Chimeric antigen receptor molecules and uses thereof

DIMERIZATION SWITCHES AND USES THEREOF

OMA1 activity assay

COMPOSITIONS AND METHODS FOR IDENTIFYING ENZYME MODULATORS OR INHIBITORS

Compositions and methods for inhibition of lineage specific antigens

Compositions and methods for inhibition of lineage specific antigens

T cell receptor-deficient chimeric antigen receptor T-cells and methods of use thereof

Nucleic acid molecules

T CELL RECEPTOR-DEFICIENT CHIMERIC ANTIGEN RECEPTOR T-CELLS AND METHODS OF USE THEREOF

ENGINEERED CELLS & METHODS

Cell

CHIMERIC ANTIGEN RECEPTORS AND METHODS OF THEIR USE

Modified Zika virus NS1 protein with reduced cross-reactive immunogenicity

METHODS AND COMPOSITIONS FOR T-CELL IMMUNOTHERAPY

Methods for selectively expanding and enriching cells transduced with chimeric antigen receptors and treating HIV infection

Chimeric T cell

Antigen binding regions against fibronectin type III domains and methods of using the same

CD27L collectin fusion proteins and encoding nucleic acids

DNA vaccine against virus of Yellow Fever

Genetically modified chicken egg with an exogenous sequence knocked into the ovalbumin gene

Vinylisomerase-dehydratases, alkenol dehydratases, linalool dehydratases and crotyl alcohol dehydratases and methods for making and using them

Recombinant Elastase Proteins and Methods of Manufacturing and Use Thereof

Synthetic protein for modulating gene expression

Conditionally Active Chimeric Antigen Receptors for Modified T-Cells

Listeria-based compositions comprising a peptide minigene expression system and methods of use thereof

Targeted protein degradation

Therapeutic agents

Generation of antigen-specific TCRs

Dendritic cell composition

Lymphocyte cell lines and uses thereof

CONSTRUCTS FOR EXPRESSING LYSOSOMAL POLYPEPTIDES

Compositions for Treating Ectopic Calcification Disorders, and Methods Using Same

Multi-Span Chimeric Antigen Receptor

TREATING CARDIOVASCULAR OR RENAL DISEASES

Chimeric antigen receptor targeting human NKG2DL and methods of preparing said receptor and pharmaceutical composition

Expression of novel cell tags

Methods and compositions for reducing the immunogenicity of chimeric notch receptors

Human alpha-N-acetylgalactosaminidase polypeptide

Immune cell compositions and methods of using same

Chimeric antigen receptors targeting B-cell maturation antigen and uses thereof

AAV with unique capsid protein VP1 and methods of using for treatment

MODIFIED HEMATOPOIETIC STEM/PROGENITOR AND NON-T EFFECTOR CELLS, AND USES THEREOF

Compositions and methods for treating cancer with anti-CD19/CD20 immunotherapy

Heterodimeric vascular endothelial growth factor and use thereof

Genetically modified cells and uses thereof

Methods of treatment with natural killer cells matched for killer immunoglobulin receptor type

RNA-guided nucleic acid modifying enzymes and methods of use thereof

Synthetic notch protein for modulating gene expression

Anti-CD276 chimeric antigen receptors

Methods and compositions relating to chimeric antigen receptors

INFLUENZA NUCLEIC ACID MOLECULES AND VACCINES MADE THEREFROM

Filovirus consensus antigens, nucleic acid constructs and vaccines made therefrom, and methods of using same

ROR1 antibody compositions and related methods

Conditionally active chimeric antigen receptors for modified T-cells

Methods to spatially profile protease activity in tissue and sections

Triple-mode system for antibody maturation, surface display and secretion

Genetically encoded potassium ion indicators

Tumor-specific anti-EGFR antibody and application thereof

Chimeric polypeptides, polynucleotides encoding same, cells expressing same and methods of producing same